Serbia starts production of Sputnik V vaccine
Image by Dmitriy Kandinskiy / Shutterstock.com
Belgrade's Institute of Virology, Torlak, officially started producing Russia's Sputnik V COVID-19 vaccine on Serbian soil on Friday (June 4), the press service of Serbian Innovation and Technological Development Minister Nenad Popović, who also chairs the parliamentary friendship group with Russia, told news agency TASS.
Serbia began vaccinations with Sputnik in early January.
The Russian Direct Investment Fund (RDIF) said on March 24 it has signed an agreement with Serbian vaccines institute Torlak to produce the Sputnik V coronavirus vaccine in Serbia.
Moscow in April announced the start of production of its Sputnik V coronavirus vaccine in Serbia, the first European country outside Russia and Belarus to begin manufacturing the jab. On May 19, Russia's Gamaleya National Research Institute confirmed the quality of the Sputnik V trial vaccine manufactured in Torlak Institute.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.